Reshape ApS
Core data
Name | Reshape ApS |
Address | Østbanegade 55 1 th, 2100, København Ø |
Founded | Nov 23, 2018 |
| 54 / 49 | |
Locations (P-units) | 1View locations |
Website | https://reshapebiotech.com/ |
 Instagram | @reshapebiotech |
 LinkedIn | reshape-biotech |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | Reshape ApS |
Address | Østbanegade 55 1 th, 2100, København Ø |
Founded | Nov 23, 2018 |
| 54 / 49 | |
Locations (P-units) | 1View locations |
Website | https://reshapebiotech.com/ |
| Instagram | @reshapebiotech |
| LinkedIn | reshape-biotech |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of Reshape ApS
Description
Reshape is a biotechnology software company powering laboratories with experiment-driven discovery, automated data capture, AI-powered assay analysis, and standardized QC testing workflows.
Reshape helps laboratories design experiments, automatically capture and structure experimental data, analyze assays with AI, and uncover performance trends across experimental parameters.
Company's own description on virk.dk
Reshape ApS' main activities are to develop, produce, and sell the next generation of lab automation robots as well as any related business.
Products & services
Experiment-driven discovery platform · Automated imaging and data capture · AI-powered assay analysis · Secure cloud collaboration and experimental data management · Standardized QC testing workflows · Predictive models for experimental data
Industries
Biotechnology · Laboratory software · Scientific data analysis
Customer types
Laboratories · Next-generation startups · Industry companies
Financials
| Reporting period | 2025/261 Apr 2025 - 31 Mar 2026DKK | ||||||
|---|---|---|---|---|---|---|---|
| Gross profit | 5,310,622 | ||||||
| Profit before tax | -42,643,506 | ||||||
| Net income | -42,643,506 | ||||||
| Total assets | 87,778,096 | ||||||
| Equity | 75,515,117 | ||||||
| Avg. employees | 56 | ||||||
2020–2026 Unlock financial history | |||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Carl-Emil Grøn Fuglesang | Roles Management | TitlesDIREKTØR |
| Daniel Storgaard | Roles Management | TitlesDIREKTØR |
| Magnus Nyborg Madsen | Roles Management | TitlesDIREKTØR |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| KPMG | AuditorSimon Vinberg Andersen | RoleState Authorised Public Accountant | FromJul 15, 2026 |
| KPMG | Auditor— | RoleStatsautoriseret Revisionspartnerselskab | FromJul 15, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
Foreign legal entity | Ownership100 % | Voting rights100 % | FromMar 4, 2021 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| 🇺🇸Reshape Biotech Inc. | Ownership through Direct | 100 % |